lobbying_activities: 3402253
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3402253 | a116fa97-8cdf-4dfd-8d04-dda85d35d830 | Q2 | AARP | 1694 | AARP | 2025 | second_quarter | PHA | H.R. 1, One Big Beautiful Bill Act. S. 1862/ H.R. 946, the Optimizing Research Progress Hope And New Cures (ORPHAN Cures) Act. S. 832, the Ensuring Pathways to Innovative Cures (EPIC) Act of 2025. H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. No bill number. Discussed the Medicare drug price negotiation program. Discussed pharmacy benefit manager reforms. S. 229/ H.R. 3789, the Drug-Price Transparency for Consumers (DTC) Act of 2025. S. 1096, Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. S. 1040, Drug Competition Enhancement Act. S. 1041, Affordable Prescriptions for Patients Act. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 5120000 | 0 | 0 | 2025-07-21T08:02:45-04:00 |